Lung Cancer News and Research

RSS
Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).
Elderly LS-SCLC patients show similar results to younger counterparts for concurrent chemo-radiotherapy

Elderly LS-SCLC patients show similar results to younger counterparts for concurrent chemo-radiotherapy

IU Philanthropic Venture Fund commits to invest $500,000 to NERx Biosciences company

IU Philanthropic Venture Fund commits to invest $500,000 to NERx Biosciences company

New evidence reveals link between antioxidant intake and increased tumor growth

New evidence reveals link between antioxidant intake and increased tumor growth

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Scientists find ways to block nitration of amino acids to improve cancer immunotherapy

Scientists find ways to block nitration of amino acids to improve cancer immunotherapy

LKSOM and Hunter jointly receive $13.5 million grant from National Cancer Institute

LKSOM and Hunter jointly receive $13.5 million grant from National Cancer Institute

Aggressive local therapy for stage IV lung cancer patients improves progression-free survival

Aggressive local therapy for stage IV lung cancer patients improves progression-free survival

Bigger brains linked to greater risk of developing tumors

Bigger brains linked to greater risk of developing tumors

Raman microscopy can help detect cancer drug resistance

Raman microscopy can help detect cancer drug resistance

SBRT found to be safe treatment for patients with multiple metastases

SBRT found to be safe treatment for patients with multiple metastases

New medical navigation system receives international innovation award

New medical navigation system receives international innovation award

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC

Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

Study: Targeting specific genomic mutation in breast cancer improves survival

Study: Targeting specific genomic mutation in breast cancer improves survival

Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer

Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer

Study findings could set new standard of care for advanced anal cancer

Study findings could set new standard of care for advanced anal cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas